Hans Jörg Reinhardt is a German businessperson who has been at the helm of 9 different companies. Presently, Dr. Reinhardt holds the position of Chairman for Institute of Molecular & Clinical Ophthalmology Basel and Independent Non-Executive Chairman of Novartis AG, Chairman-Supervisory Board at Novartis International AG, Chairman for Novartis Institutes for Biomedical Research, Inc., Chairman-Supervisory Board at Novartis Pharma AG and Chairman of Novartis, Inc. (which are all subsidiaries of Novartis AG). Hans Jörg Reinhardt is also on the board of Swiss Re AG and Chairman of Novartis Foundation and Council Member at International Federation of Pharmaceutical Manufacturers.
In his past career Dr. Reinhardt occupied the position of Chairman of Genomics Institute of The Novartis Research Foundation, Chief Operating Officer at Novartis AG and Head-Development at Sandoz Pharmaceuticals AG (a subsidiary of Novartis AG) and Chairman-Management Board at Bayer HealthCare AG.
Hans Jörg Reinhardt received a doctorate from Universität des Saarlandes.